Search Orphan Drug Designations and Approvals
-
Generic Name: | antisense oligonucleotide complementary to the exonic splicer enhancer sequence at intron 26 of the centrosomal protein 290 pre-mRNA |
---|---|
Date Designated: | 05/25/2016 |
Orphan Designation: | Treatment of Leber's congenital amaurosis. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ProQR Therapeutics IV B.V. Zernikedreef 9 Leiden 2333 CK Netherlands The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-